Taiwan Diabetes Registry

• Sponsor: The Diabetes Association of the Republic of China (Taiwan) (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT06143449
• Collaborator: (none)
• Enrollment: 24,000
• Location: 1
• Anticipated Duration (Months): 183
• Patients Per Site Per Month: 131.1

Study Details

Study Description

Brief Summary

To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease，Macrovascular Disease and Neuropathy in Patients With Diabetes.

Condition or Disease	Intervention/Treatment	Phase
Diabetes Mellitus	Other: Observational study - registry

Detailed Description

At the first year (2015), the patients ever enrolled into the quality control study by Taiwan Association of Diabetes Educators in 2006 and 2011 will be recruited, and their relevant clinical data will be regularly registered yearly until 2030. In addition, it is planned that type 1 diabetic patients will be enrolled, and their clinical data will be regularly recorded yearly until 2030. Also, newly diagnosed type 2 diabetic patients will be recruited, and their clinical data will be regularly entered to the diabetes web-based system yearly until 2030. We will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030. Finally, we will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030.

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 24000 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Taiwan Diabetes Registry (TDR)
• Actual Study Start Date: Oct 1, 2015
• Anticipated Primary Completion Date: Dec 31, 2030
• Anticipated Study Completion Date: Dec 31, 2030

Outcome Measures

Primary Outcome Measures

1. Provide data on patient characteristics [Ten years]

2. Provide data on disease management. [Ten years]

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Diagnosis of diabetes mellitus

Exclusion Criteria:

• Patients who do not have diabetes mellitus

• Participating in an interventional trial requiring informed consent

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	The Diabetes Association of the Republic of China (Taiwan)	Taipei		Taiwan	10046

Sponsors and Collaborators

• The Diabetes Association of the Republic of China (Taiwan)

Investigators

• : The Diabetes Association of the Republic of China (Taiwan),

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: The Diabetes Association of the Republic of China (Taiwan)
• ClinicalTrials.gov Identifier: NCT06143449
• Other Study ID Numbers: Taiwan Diabetes Registry
• First Posted: Nov 22, 2023
• Last Update Posted: Nov 29, 2023
• Last Verified: Nov 1, 2023

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Diabetes Mellitus

Study Results

No Results Posted as of Nov 29, 2023